Ikarian Capital’s Immunic IMUX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $638K | Hold |
914,170
| – | – | 0.12% | 61 |
|
|
2025
Q1 | $996K | Sell |
914,170
-700,000
| -43% | -$763K | 0.12% | 63 |
|
|
2024
Q4 | $1.61M | Buy |
1,614,170
+1,120,674
| +227% | +$1.12M | 0.22% | 53 |
|
|
2024
Q3 | $814K | Hold |
493,496
| – | – | 0.11% | 63 |
|
|
2024
Q2 | $548K | Sell |
493,496
-1,118,882
| -69% | -$1.24M | 0.1% | 67 |
|
|
2024
Q1 | $2.13M | Buy |
+1,612,378
| New | +$2.13M | 0.23% | 42 |
|
|
2023
Q4 | – | Sell |
-450,000
| Closed | -$662K | – | 96 |
|
|
2023
Q3 | $662K | Sell |
450,000
-200,000
| -31% | -$294K | 0.08% | 52 |
|
|
2023
Q2 | $1.63M | Hold |
650,000
| – | – | 0.26% | 38 |
|
|
2023
Q1 | $969K | Hold |
650,000
| – | – | 0.22% | 59 |
|
|
2022
Q4 | $910K | Buy |
+650,000
| New | +$910K | 0.22% | 39 |
|
|
2022
Q3 | – | Sell |
-61,500
| Closed | -$214K | – | 90 |
|
|
2022
Q2 | $214K | Buy |
+61,500
| New | +$214K | 0.04% | 79 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 166 |
|